4s3 Raises $20M to Create Protein Therapies for Orphan Neuromuscular Disorders
Antibody-based system allows cellular delivery of macromolecules via ENT2 transporter. 4s3 Bioscience raised $20 million through a Series A financing round with KLP Enterprises to fund further development of i…
Read guide →